A new office and laboratory incubator for emerging biotechnology and life science companies has just opened in Newton’s Charles River Mill District.

With occupancy nearing 90% across its existing facilities, Labshares is expanding to more than 100,000 square feet to meet demand for flexible, capital-efficient lab space that helps biotechs scale smarter and focus on science.

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, has entered into a strategic agreement valued at up to $202 million with an undisclosed, large commercial-stage biopharmaceutical company ...